["{\n\"step_by_step_thinking\": \"The relevant documents suggest that risperidone has a unique pharmacology of potent antagonism of both serotonin and dopamine receptors. It does not differ from placebo on assessment scales of extrapyramidal side effects, but produces significantly less than did haloperidol. There were no major adverse reactions associated with risperidone use, but it was noted to reduce the signs of tardive dyskinesia.\",\n\"answer_choice\": \"D\"\n}"]